2025 Year in Review: Breakthroughs, Milestones & Moments That Defined ISB
From Nobel recognition and scientific firsts to transformative collaborations and community impact, 2025 marked one of the most significant years in ISB’s 25-year history.
Back to Previous Page
ISB News
Health
-
- All Categories
- Advancing Health
- Autoimmune Diseases
- Baliga Lab
- Brain Health
- Cancer
- Cancer Tipping Points
- Chronic Illness
- Climate Change
- Courses and Symposia
- COVID and Long COVID
- CyberGut
- Early Detection and Diagnosis
- Education
- Environment
- Events
- Fellows
- Gibbons Lab
- Hadlock Lab
- Hands-on Learning
- Health
- Health Data Science Lab
- Health Equity
- Healthspan and Longevity
- Heath Lab
- Hood Lab
- Huang Lab
- Infectious Disease
- Internships
- ISB-Town Hall
- Kane Lab
- Kuchina Lab
- Logan Center for Education
- Lyme Disease
- Malaria
- Maternal and Infant Health
- Microbiome
- Moritz Lab
- My Digital Gut
- Neurological Disorders
- Optimizing Outcomes
- People
- Philanthropy
- Precision Treatments
- Press Release
- Proteins and Disease
- Ranish Lab
- Real-world Science
- Research Roundtable
- Subramanian Lab
- Sustainability and Remediation
- SYGNAL
- Systemic Change
- Systems Education Experiences
- Thorsson-Shmulevich Lab
- Treatments and Resistance
- Tuberculosis
- Understanding Tumors
- Venkatesh Lab
- Wei Lab
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
Microbial Metabolites and Human Health Take Center Stage at ISB’s 2025 Virtual Microbiome Symposium
Six leading experts from across the field presented new insights to more than 1,000 registrants worldwide, with over 400 participants joining live.
Eric Topol and Lee Hood — Two Scientific Luminaries on Longevity and Prevention
Discussing Super Agers, Drs. Eric Topol and Lee Hood connected breakthroughs in genomics, AI, and lifestyle science to the pursuit of longer, healthier lives.
Disarming a Hidden Killer: Predicting – and Preventing – C. diff Before It Strikes
Researchers at ISB have developed personalized models to predict C. diff colonization risk and test targeted probiotics. This approach could prevent infection before it starts and paves the way for precision microbiome therapies tailored to individual gut ecosystems.
A Simpler, Smarter Way to Measure Gut Bacterial Biomass
ISB scientists have developed a simple, low-cost method to measure the total amount of bacteria in the gut using existing sequencing data. This breakthrough could speed up microbiome research and unlock new insights into health and disease.
New Tool Unlocks Biomedical Discovery with Launch of Biomedical Data Translator
The Biomedical Data Translator is now publicly available, offering a powerful open-source platform that integrates diverse biomedical datasets. Designed to accelerate discovery and patient care, Translator helps users explore complex data and uncover actionable insights with ease.